SCHEMBL25834234

SCHEMBL25834234

CCCCC[N+](C)(C)CCOCCOCC[N+](C)(C)CCCCO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 7/20 0.59
HTT P42858 3/20 0.52
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
THRB P10828 1/20 0.48
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TSHR P16473 1/20 0.44
MLNR O43193 1/20 0.44
NR1I2 O75469 1/20 0.44
ESR1 P03372 1/20 0.44
NR3C1 P04150 1/20 0.44
PGR P06401 1/20 0.44
ADRB2 P07550 1/20 0.44
CHRM2 P08172 1/20 0.44
ADRB1 P08588 1/20 0.44
HTR1A P08908 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25834238 0.98 DNM1 (0.61) DNM1HTTKMT2AMEN1THRB
Iodide SCHEMBL8912913 0.91 DNM1 (0.58) DNM1HTTKMT2AMEN1THRB
SCHEMBL25834235 0.90 DNM1 (0.50) DNM1HTTKMT2AMEN1THRB
SCHEMBL4808190 0.89 DNM1 (0.64) DNM1HTTKMT2AMEN1THRB
SCHEMBL7091336 0.89 DNM1 (0.64) DNM1HTTKMT2AMEN1THRB
SCHEMBL7089797 0.89 DNM1 (0.64) DNM1HTTKMT2AMEN1THRB
SCHEMBL25834237 0.88 DNM1 (0.52) DNM1HTTKMT2AMEN1THRB
Hydrochloric Acid SCHEMBL1683335 0.87 DNM1 (0.62) DNM1HTTKMT2AMEN1THRB
Hydrochloric Acid SCHEMBL1683346 0.87 DNM1 (0.62) DNM1HTTKMT2AMEN1THRB
Hydrochloric Acid SCHEMBL4805429 0.87 DNM1 (0.62) DNM1HTTKMT2AMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents HACD3, C9, HACD2 DNM1 1502/4885HTT 657/4885KMT2A 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.